Research Article
An Innovative Immune Score-Based Prognostic Nomogram for Patients with Cervical Cancer
Table 1
Relationships between clinical pathological characteristics and immune scores in 198 cervical cancer patients.
| | Immune scores | | value | | Characteristics | Total | ≤374.3 | 374.3 to 1051.6 | >1051.6 | | |
| | Sample sizes | 198 | 97 (48.9) | 60 (30.3) | 41 (20.7) | | | | Age (y)a | | | | | 16.178 | 0.095 | | ≤40 | 66 | 32 (33.0) | 24 (40.0) | 10 (24.4) | | | | 40-50 | 61 | 35 (36.1) | 13 (21.7) | 13 (31.7) | | | | 50-60 | 39 | 17 (17.5) | 13 (21.7) | 9 (22.0) | | | | 60-70 | 22 | 11 (11.3) | 8 (13.3) | 3 (7.3) | | | | 70-80 | 9 | 2 (2.1) | 2 (3.3) | 5 (12.2) | | | | >80 | 1 | 0 (0.0) | 0 (0.0) | 1 (2.4) | | | | Race | | | | | 2.44 | 0.655 | | Asian | 20 | 8 (8.2) | 8 (13.3) | 4 (9.8) | | | | White | 146 | 76 (78.4) | 41 (68.3) | 29 (70.7) | | | | Others | 32 | 13 (13.4) | 11 (18.3) | 8 (19.5) | | | | Grade | | | | | 8.501 | 0.204 | | I | 15 | 9 (9.3) | 5 (8.3) | 1 (2.4) | | | | II | 96 | 52 (53.6) | 26 (43.3) | 18 (43.9) | | | | III | 86 | 36 (37.1) | 29 (48.3) | 21 (51.2) | | | | IV | 1 | 0 (0.0) | 0 (0.0) | 1 (2.4) | | | | Stage | | | | | 4.748 | 0.577 | | I | 123 | 61 (62.9) | 38 (63.3) | 24 (58.5) | | | | II | 41 | 17 (17.5) | 13 (21.7) | 11 (26.8) | | | | III | 22 | 10 (10.3) | 7 (11.7) | 5 (12.2) | | | | IV | 12 | 9 (9.3) | 2 (3.3) | 1 (2.4) | | | | Histology | | | | | 32.953 | 0.000 | | Cervical squamous cell carcinoma | 158 | 62 (63.9) | 56 (93.3) | 40 (97.6) | | | | Cervical nonsquamous cell carcinoma | 40 | 35 (36.1) | 4 (6.7) | 1 (2.4) | | |
|
|
aAge at diagnosis of cervical cancer.
|
